“We gave the mice a blocker of all caspases [pancaspase inhibitor], a compound known as Q-VD-OPH, thinking it would leave both sets of mice more vulnerable to MRSA infection,” Miller says. “To our surprise, blocking caspases had the opposite effect, resulting in a rapid and remarkable clearing of the MRSA bacteria by keeping the immune cells alive and boosting their protective function.”
Sensing they might have accidentally uncovered a means of fighting bacterial “superbugs,” Miller and his colleagues conducted their latest study to confirm the unexpected finding was not a fluke.
The results were encouraging.
“A single oral dose of Q-VD-OPH decreased the size of MRSA skin lesions and rapidly cleared the bacteria compared with vehicle-treated [given the carrier solution without Q-VD-OPH] and untreated mice,” says study lead author Martin Alphonse, Ph.D., a dermatology postdoctoral fellow at the Johns Hopkins University School of Medicine. “And surprisingly, the treatment worked whether IL-1β was present or not—and without administering any antibiotics.”
- Campus Crusade for Christ Goes All In On Critical Race Theory
- Is the Pope Dying? 2022 Conclave?
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- Media Trying to Destroy Rosanne Boyland Before Truth about Her Jan 6 Death is exposed.
- Tokyo Medical Association Chairman Haruo Ozaki on Ivermectin
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin
- Holy Smokes! Kevin McCarthy Lives With Frank Luntz!
- AT&T To Remove One America News Network From Lineup
- Orwell’s Classic novel 1984 to be retold as a feminist social justice narrative in which the Julia character “is happy with her life.”